These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2411951)

  • 21. Cytotoxic T cell activity against the 22-kDa protein of human respiratory syncytial virus (RSV) is associated with a significant reduction in pulmonary RSV replication.
    Nicholas JA; Rubino KL; Levely ME; Meyer AL; Collins PL
    Virology; 1991 Jun; 182(2):664-72. PubMed ID: 2024493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.
    Sparer TE; Wynn SG; Clark DJ; Kaplan JM; Cardoza LM; Wadsworth SC; Smith AE; Gooding LR
    J Virol; 1997 Mar; 71(3):2277-84. PubMed ID: 9032363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells.
    Kast WM; de Waal LP; Melief CJ
    J Exp Med; 1984 Dec; 160(6):1752-66. PubMed ID: 6096476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection.
    Chang J; Srikiatkhachorn A; Braciale TJ
    J Immunol; 2001 Oct; 167(8):4254-60. PubMed ID: 11591747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
    Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins.
    Nicholas JA; Rubino KL; Levely ME; Adams EG; Collins PL
    J Virol; 1990 Sep; 64(9):4232-41. PubMed ID: 2117070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary pulmonary murine cytotoxic T lymphocyte specificity in respiratory syncytial virus pneumonia.
    Gupta R; Yewdell JW; Olmsted RA; Collins PL; Bennink JR
    Microb Pathog; 1990 Jul; 9(1):13-8. PubMed ID: 2077342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.
    Cannon MJ; Openshaw PJ; Askonas BA
    J Exp Med; 1988 Sep; 168(3):1163-8. PubMed ID: 3262705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen.
    Pemberton RM; Cannon MJ; Openshaw PJ; Ball LA; Wertz GW; Askonas BA
    J Gen Virol; 1987 Aug; 68 ( Pt 8)():2177-82. PubMed ID: 3497222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection.
    Moskophidis D; Assmann-Wischer U; Simon MM; Lehmann-Grube F
    Eur J Immunol; 1987 Jul; 17(7):937-42. PubMed ID: 2886344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection.
    Lee S; Miller SA; Wright DW; Rock MT; Crowe JE
    J Virol; 2007 Mar; 81(5):2349-58. PubMed ID: 17182672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope.
    Zeng RH; Gong W; Fan CF; Wang YF; Mei XG
    Vaccine; 2006 Feb; 24(7):941-7. PubMed ID: 16159685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness.
    Zinkernagel RM; Althage A; Cooper S; Kreeb G; Klein PA; Sefton B; Flaherty L; Stimpfling J; Shreffler D; Klein J
    J Exp Med; 1978 Aug; 148(2):592-606. PubMed ID: 212503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responses.
    Melendi GA; Bridget D; Monsalvo AC; Laham FF; Acosta P; Delgado MF; Polack FP; Irusta PM
    Virus Genes; 2011 Feb; 42(1):46-54. PubMed ID: 21053062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic T lymphocyte response to minor H-43a alloantigen in H-43b mice. Privileged H-2Kb restriction to the response is not due to immunodominance or epistatic effect but due to Ir gene function of H-2Kb itself.
    Hino T; Ishikawa H; Saito K
    J Immunol; 1988 Jan; 140(1):44-51. PubMed ID: 3121741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse.
    Tripp RA; Jones L; Anderson LJ; Brown MP
    J Immunol; 2000 Jun; 164(11):5913-21. PubMed ID: 10820273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.
    An LL; Whitton JL
    J Virol; 1997 Mar; 71(3):2292-302. PubMed ID: 9032365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The beta2 integrin CD11c distinguishes a subset of cytotoxic pulmonary T cells with potent antiviral effects in vitro and in vivo.
    Beyer M; Wang H; Peters N; Doths S; Koerner-Rettberg C; Openshaw PJ; Schwarze J
    Respir Res; 2005 Jul; 6(1):70. PubMed ID: 16011799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.